TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
JMVA Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 918 | 862 | 939 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 496 | 242 | 159 |
EBITDA | 475 | 240 | 159 |
Total assets | 1,492 | 1,464 | 1,735 |
Current assets | 1,492 | 1,464 | 1,735 |
Current liabilities | 16 | 10 | 142 |
Equity capital | 1,437 | 1,410 | 1,545 |
- share capital | 34 | 33 | 36 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 96.3% | 96.3% | 89.0% |
Turnover per employee | 918 | 862 | 939 |
Profit as a percentage of turnover | 54.0% | 28.1% | 16.9% |
Return on assets (ROA) | 33.2% | 16.5% | 9.2% |
Current ratio | 9325.0% | 14640.0% | 1221.8% |
Return on equity (ROE) | 34.5% | 17.2% | 10.3% |
Change turnover | 52 | -1 | -432 |
Change turnover % | 6% | 0% | -31% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.